Depression Clinical Trial
— ESTEEMOfficial title:
Intervention Development for Social Stress, Mental Health, and HIV Risk Among MSM
| Verified date | May 2015 |
| Source | Yale University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: National Institute of Health |
| Study type | Interventional |
The proposed study will adapt a cognitive behavioral intervention to support high-risk MSM's adaptive coping with minority stress, alleviate associated depression and anxiety, and reduce HIV risk behavior. The adapted intervention is expected to increase awareness of the unhealthy impact of minority stress; facilitate objective self-schemas in the face of minority stress; and strengthen one's skills and self-efficacy for managing minority stress and associated anxiety and depression to reduce risk for acquiring HIV.
| Status | Completed |
| Enrollment | 63 |
| Est. completion date | December 2014 |
| Est. primary completion date | December 2014 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 35 Years |
| Eligibility |
Inclusion Criteria: 1. Subjective stress related to sexual identity over the previous three months; 2. Symptoms of depression or anxiety within the past three months; 3. HIV sexual risk behavior (one or more acts of condomless insertive or receptive anal sex with a male partner of unknown or discordant serostatus) within the past three months; 4. Biological male gender; 5. At least 18 years of age; 6. Not known to have HIV; 7. Residential stability and availability for six months; 8. Ability to communicate in English; and 9. Provision of informed consent. Exclusion Criteria: 1. active, unmedicated symptoms of bipolar I or bipolar II disorder or any Diagnostic and Statistical Manual-IV psychotic disorder in the past 12 months; 2. Current suicidal or homicidal ideation; 3. Evidence of gross cognitive impairment; 4. Current enrollment in an HIV-related intervention or research study; and 5. Knowledge of being infected with HIV. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Yale University | Hunter College |
Pachankis JE. Uncovering Clinical Principles and Techniques to Address Minority Stress, Mental Health, and Related Health Risks Among Gay and Bisexual Men. Clin Psychol (New York). 2014 Dec;21(4):313-330. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | reductions in the number of condomless anal sex acts in the past 90 days with HIV-positive or HIV-status-unknown male partners | 3 months | No | |
| Secondary | reduction in depression severity as measured with the Center for Epidemiological Studies Depression Scale | 3 months | No | |
| Secondary | reduction in anxiety severity as measured with the Overall Anxiety Severity & Impairment Scale | 3 months | No | |
| Secondary | reduction in minority stressors as measured with the Sexual Orientation Concealment Scale | 3 months | No | |
| Secondary | reductions in psychological risk factors measured with the Ruminative Responses Scale | 3 months | No | |
| Secondary | reductions in number of days in which heavy alcohol and potentially harmful recreational substances were use | 3 months | No | |
| Secondary | among individuals with body image disturbance, improvements in body attitudes as measured with the Male Body Attitude Scale | 3 months | No | |
| Secondary | among individuals with sexual compulsivity, reduction in sexual compulsivity severity as measured with the Sexual Compulsivity Scale | 3 months | No | |
| Secondary | reduction in alcohol use problems as assessed with the Alcohol Use Disorders Identification Test | 3 months | No | |
| Secondary | in participants with generalized anxiety disorder, reduction in Penn State Worry Questionnaire | 3 months | No | |
| Secondary | reduction in depression severity as measured with the Overall Depression Severity & Impairment Scale | 3 months | No | |
| Secondary | reduction in anxiety severity as measured with the State Trait Anxiety Inventory (State subscale) | 3 months | No | |
| Secondary | reduction in minority stressors as measured with the Internalized Homophobia Scale | 3 months | No | |
| Secondary | reduction in minority stressors as measured with the Rejection Sensitivity Scale | 3 months | No | |
| Secondary | reductions in psychological risk factors measured with the Rathus Assertiveness Schedule | 3 months | No | |
| Secondary | reductions in psychological risk factors measured with the Difficulties of Emotion Regulation Scale | 3 months | No | |
| Secondary | reductions in psychological risk factors measured with the Multidimensional Scale of Perceived Social Support | 3 months | No | |
| Secondary | in participants with obsessive-compulsive disorder, reductions in the Yale-Brown OC Scale | 3 months | No | |
| Secondary | in participants with panic disorder, reduction in the Panic Disorder Severity Scale | 3 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
| Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
| Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
| Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
| Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
| Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
| Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
| Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
| Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
| Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
| Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
| Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
| Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
| Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
| Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |